Mepolizumab

ATC R03DX09 · 10 markets · 28 records

Mepolizumab 10 markets · 28 records Forms

AU 6 records · 3 strengths

  • 100 mginjectionNUCALA mepolizumab 100 mg powder forNUCALA mepolizumab 100 mg solution for injection in pre-filled pen、NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe also in GB·US·ES +1 unknown
  • 100 mg/1 mLinjectionNucala also in GB

Records without a stated strength · 1 Nucala

GB 4 records · 3 strengths

US 3 records · 2 strengths

CA 3 records · 2 strengths

ES 3 records · 2 strengths

SG 2 records · 2 strengths

  • 40 mg/0.4 mLinjectionNUCALA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 40MG/0.4ML also in GB·US
  • 100 mg/mLinjectionNUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML

TW 2 records · 2 strengths

Records without a stated strength · 1 Nucala Powder for Solution for Injection、舒肺樂凍晶注射劑

HK 1 records · 1 strengths

    Records without a stated strength · 1 NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/1ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Nucala

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.